Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Kk Women'S and Children'S Hospital, Singapore, Singapore
Cipto Mangunkusumo Central National Hospital, Jakarta, DKI Jakarta, Indonesia
Division de Anestesia - Pontificia Universidad Catolica de Chile, Santiago, Region Metropolitana, Chile
West China Hospital of Sichuan University, Department of Anesthesiology, Chengdu, Sichuan, China
Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China, Shanghai, Shanghai, China
West China Second University Hospital, Chengdu, Sichuan, China
Assiut University hospital, Assiut, Asyut Governorate, Egypt
Third Central Hospital of Tianjin, Tianjin, Tianjin, China
Seoul National Univ. Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.